Azulene Labs
Physics-grounded AI foundation models trained on quantum-mechanical data for drug and materials design
Azulene Labs is a Berkeley, California startup building physics-based AI foundation models for chemistry. Its models are trained on quantum-mechanical data so they stay within physical law, aimed at making molecular simulation (for example, drug-protein binding affinity) predictive rather than trial-and-error. The company claims about 100x the efficiency of competing tools and at least 200x cheaper training-data generation, with target uses in pharma, agriculture, energy storage, industrial solvents and biodegradable plastics. It was founded by CEO Dr Nicolas Sawaya, a Harvard chemical-physics PhD who previously led quantum algorithm development for chemistry at Intel Labs; the founding team includes PhDs from Caltech, Harvard, UC Berkeley, Columbia and MIPT. In September 2026 it raised an oversubscribed $3.4M pre-seed led by Ground State Ventures, with Entrada Ventures and angels, to grow its team and product. It works with biotech and industrial-chemistry customers.
AI
📍 Berkeley, CA
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Azulene Labs going public?
No. Azulene Labs is private and has not filed to go public. There is no S-1 on file.
What is Azulene Labs' valuation in 2026?
No confirmed valuation is on record for Azulene Labs. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Azulene Labs filed an S-1?
No public S-1 is on file for Azulene Labs.
Who are Azulene Labs' investors?
Azulene Labs' investors include Ground State Ventures, Entrada Ventures.
How much has Azulene Labs raised?
Azulene Labs has raised $3.4M in total across 1 disclosed round, most recently a Pre-seed of $3.4M in Sep 2026.
Is Azulene Labs publicly traded — can you buy Azulene Labs stock?
No. Azulene Labs is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Azulene Labs on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Last Round
Pre-seed — $3.4M (Sep 2026) · Lead: Ground State Ventures
Fundraising Status
Pre-seed · $3.4M · this month
privateTotal raised $3.4M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Pre-seed | $3.4M | Sep 2026 | Ground State Ventures | — |
Vertical Intelligence — Biotech / Gene Therapy
Biotech / Gene Therapy registry data for Azulene Labs has not been collected yet — the weekly vertical sweep hasn't reached this company. Check back soon.
Talent Signal
Hiring data for Azulene Labs has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
Investors
Ground State Ventures · Entrada Ventures
Products
- Physics-based chemistry foundation models
AIChemistryDrug DiscoveryMaterials ScienceQuantum ChemistryFoundation Models
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.